Spectris Plc is a holding company, which engages in the manufacture, development, and supply of measuring instruments and controls. It operates through the following segments: The Malvern ...

CAMBRIDGE, Mass., February 11, 2025--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, today announced the publication ...

Spectris plc has a fifty-two week low of GBX 2,370 ($29.29) and a fifty-two week high of GBX 3,730 ($46.09). The company has a debt-to-equity ratio of 4.37, a current ratio of 2.36 and a quick ...

Spectris plc has agreed to acquire Micromeritics Instrument Corporation for $630 million (485 million pounds). This is stated in the message of Spectris. The acquisition will be financed by a ...

Britain's Spectris said on Thursday that the persistent softness in the Chinese market is likely to continue into the early part of 2025, after the scientific instruments maker cut its annual ...

The study, titled “CSF Proteomics Reveals Changes in Myelin and Synaptic Biology Following Spectris™ Treatment,” offers compelling evidence of Spectris™’ ability to modulate core ...